188 related articles for article (PubMed ID: 31760649)
1. Roads to Formation of Normal Myelin Structure and Pathological Myelin Structure.
Bando Y
Adv Exp Med Biol; 2019; 1190():257-264. PubMed ID: 31760649
[TBL] [Abstract][Full Text] [Related]
2. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
3. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
4. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
5. Axonal pathology in myelin disorders.
Bjartmar C; Yin X; Trapp BD
J Neurocytol; 1999; 28(4-5):383-95. PubMed ID: 10739578
[TBL] [Abstract][Full Text] [Related]
6. Axonal loss in multiple sclerosis: causes and mechanisms.
Criste G; Trapp B; Dutta R
Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
[TBL] [Abstract][Full Text] [Related]
7. Promoting myelin repair and return of function in multiple sclerosis.
Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
[TBL] [Abstract][Full Text] [Related]
9. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
Onuki M; Ayers MM; Bernard CC; Orian JM
Microsc Res Tech; 2001 Mar; 52(6):731-9. PubMed ID: 11276125
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis and basis for treatment in multiple sclerosis.
Compston A
Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
[TBL] [Abstract][Full Text] [Related]
11. Immunological aspects of axon injury in multiple sclerosis.
Howe CL
Curr Top Microbiol Immunol; 2008; 318():93-131. PubMed ID: 18219816
[TBL] [Abstract][Full Text] [Related]
12. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
13. A unified cell biological perspective on axon-myelin injury.
Simons M; Misgeld T; Kerschensteiner M
J Cell Biol; 2014 Aug; 206(3):335-45. PubMed ID: 25092654
[TBL] [Abstract][Full Text] [Related]
14. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
Simkins TJ; Duncan GJ; Bourdette D
Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
[TBL] [Abstract][Full Text] [Related]
15. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
16. Remyelination protects axons from demyelination-associated axon degeneration.
Irvine KA; Blakemore WF
Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
[TBL] [Abstract][Full Text] [Related]
17. Pathological findings in rats with experimental allergic encephalomyelitis.
Dong M; Liu R; Guo L; Li C; Tan G
APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
[TBL] [Abstract][Full Text] [Related]
18. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
[TBL] [Abstract][Full Text] [Related]
19. Demyelination in multiple sclerosis.
Lubetzki C; Stankoff B
Handb Clin Neurol; 2014; 122():89-99. PubMed ID: 24507514
[TBL] [Abstract][Full Text] [Related]
20. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis.
Penkowa M; Hidalgo J
J Neurosci Res; 2003 Jun; 72(5):574-86. PubMed ID: 12749022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]